Cancer

Graphical Dirichlet Process for Clustering Non-Exchangeable Grouped Data

Graphical Dirichlet process.

Covariate-Assisted Bayesian Graph Learning for Heterogeneous Data

A new Gaussian graphical model that produces subject-specific and predictive graphs with theoretical guarantee.

Individualized Causal Discovery with Latent Trajectory Embedded Bayesian Networks

Individualized causal discovery.

Individualized Inference in Bayesian Quantile Directed Acyclic Graphical Models

Graphical Dirichlet process.

Bayesian Covariate-Dependent Gaussian Graphical Models with Varying Structure

A new Gaussian graphical model that produces subject-specific and predictive graphs with theoretical guarantee.

Bayesian Hierarchical Quantile Regression with Application to Characterizing the Immune Architecture of Lung Cancer

The successful development and implementation of precision immuno-oncology therapies requires a deeper understanding of the immune architecture at a patient level. T-cell Receptor (TCR) repertoire sequencing is a relatively new technology that …

Rejoinder to the Discussion of "Bayesian Graphical Models for Modern Biological Applications."

A review of Bayesian graphical models for biological applications.

Bayesian Graphical Models for Modern Biological Applications

A review of Bayesian graphical models for biological applications.

Heterogeneity of Human Prostate Carcinoma-Associated Fibroblasts Implicates a Role for Subpopulations in Myeloid Cell Recruitment

Carcinoma–associated fibroblasts (CAF) are a heterogeneous group of cells within the tumor microenvironment (TME) that can promote tumorigenesis in the prostate. By understanding the mechanism(s) by which CAF contributes to tumor growth, new …

Bayesian Hierarchical Varying-sparsity Model with Application to Cancer Proteogenomics

A Bayesian hierarchical varying-sparsity regression (BEHAVIOR) model that selects clinically relevant disease markers by integrating proteogenomic and clinical data.

Bayesian Graphical Regression

A new directed acyclic graphical model that produces subject-specific and predictive graphs with theoretical guarantee.

Parallel-Tempered Feature Allocation for Large-Scale Tumor Heterogeneity with Deep Sequencing Data

We develop a parallel-tempered feature allocation algorithm to infer tumor heterogeneity from deep DNA sequencing data. The feature allocation model is based on a binomial likelihood and an Indian Buffet process prior on the latent haplotypes. A …

Heterogeneous Reciprocal Graphical Models

A hierarchical reciprocal graphical models to infer gene networks from heterogeneous data with or without known groups.

Reciprocal Graphical Models for Integrative Gene Regulatory Network Analysis

A Gaussian reciprocal graphical model for inference about gene regulatory relationships by integrating mRNA gene expression and DNA level information including copy number and methylation.

Bayesian Graphical Models for Computational Network Biology

A review of directed, undirected, and reciprocal graphs.

Sparse Multi-Dimensional Graphical Models: A Unified Bayesian Framework

An array-variate directed acyclic graphical model for tensor data.

Variance in Estimated Pairwise Genetic Distance Under High versus Low Coverage Sequencing: the Contribution of Linkage Disequilibrium

A dose insertion design for phase I/II clinical trials in oncology based on both efficacy and toxicity outcomes.

Bayesian Approaches for Large Biological Networks

Bayesian methods have found many successful applications in high-throughput genomics. We focus on approaches for network-based inference from gene expression data. Methods that employ sparse priors have been particularly successful, as they are …

Bayesian Nonlinear Model Selection for Gene Regulatory Networks

A Bayesian directed acyclic graphical model to recover the structure of nonlinear gene regulatory networks.

Integrative Bayesian Network Analysis of Genomic Data

An integrative Bayesian network approach to investigate the relationships between genetic and epigenetic alterations as well as how these mutations affect a patient’s clinical outcome.